This document provides an overview of VitreosHealth, an advanced analytics company for population health management. It describes VitreosHealth's predictive models for disease cohorts and risk factors that predict patient risks and costs with over 60% accuracy. It also outlines VitreosHealth's suite of care management tools including a State of Health Analysis and strategic process for population health management. VitreosHealth works with providers, payers, and IDNs to improve outcomes and reduce costs through predictive analytics.
Evidence Based Clinical Decision Support – An Enabler for Clinicians in 21st Century by Dr. Lalit Singh, Director for Content & Product Strategy, Elsevier, India
HxRefactored 2015: Charles Boicey "Interoperability Exercise, Triple Store & ...HxRefactored
Charles Boicey, RN and Enterprise Analytics Architect for Stony Brook Medicine shares how RDF Triples can reconcile data from multiple and disparate sources to unlock great insight.
Evidence Based Clinical Decision Support – An Enabler for Clinicians in 21st Century by Dr. Lalit Singh, Director for Content & Product Strategy, Elsevier, India
HxRefactored 2015: Charles Boicey "Interoperability Exercise, Triple Store & ...HxRefactored
Charles Boicey, RN and Enterprise Analytics Architect for Stony Brook Medicine shares how RDF Triples can reconcile data from multiple and disparate sources to unlock great insight.
Creating large scale telehealth network : A story from the USA by Adam Darkins, Vice President, Medical Affairs & Enterprise Technology Development, Medtronics, USA
At eClinicalWorks, we are 5,000 employees dedicated to improving healthcare together with our customers. More than 130,000 physicians nationwide — and more than 850,000 medical professionals around the globe — rely upon us for comprehensive clinical documentation, along with solutions for Practice Management, Population Health, Patient Engagement, and Revenue Cycle Management.
Providers need to move towards real-time analytics that have become critical to demonstrate their quality of care, as reimbursement by government programs can be contingent upon how providers are measured in “Quality of Care”. For example, the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, also called the Permanent Doc Fix, changes the way Medicare doctors are reimbursed with the implementation of a merit based incentive. The performance-based pressure is huge, which makes it imperative that every provider consider technology solutions. Read more at https://www.solix.com/solutions/data-driven-solutions/healthcare/
HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Manu Varma, PhilipsHxRefactored
Through new telehealth technologies and increased data analysis physicians are gaining insights into patients like never before, allowing them to facilitate early interventions, improve adherence, and reduce readmission rates -- not to mention at a price more affordable than ever. The companies you’ll hear from in this session are using a healthy and innovative mix of data, educational tools, sensors, and more to improve patient outcomes.
Patient centricity and digital solutionsAhmed Graouch
Beyond product offerings, it also positions Medtech companies to help hospitals and health systems transition to the future of health through services.
The term “digital twin” refers to the digital version of a physical device or process. By bridging the physical and the virtual worlds, data is transmitted seamlessly allowing the virtual entity to exist simultaneously with the physical device or process. Digital twins are emerging as virtual test beds for
possible solutions before they implement physical devices. These computer-based models are fed individual and population data and mimic the electrical and physical properties of an object.
Medical device companies are using this technology to simulate how their devices are being used in the
clinical setting.
In our view of the future of health, radically interoperable data is likely to play a huge role in transforming health care. Data from medical technologies such as wearables, remote monitors, and
sensors will be standardized, stored, updated, and aggregated with other sources of information such as social media platforms, retailers, and electronic health records.
The combined data will create a complete personal profile that physicians and health systems can use to help ensure that
I deliver health services in an appropriate fashion.
mHealth Israel_Hospitals and Healthcare Data_Carol Gomes_Stony Brook Universi...Levi Shapiro
Presentation by Carol Gomes, CEO / COO, Stony Brook University Hospital: Hospitals + Healthcare Data. Key Sections:
- Overview of Stony Brook Medicine Health System
- IT capital planning process
- Transition from Fee-for-Service
- Clinically Integrated Network
- Population Health Analytics Platform
- REGISTRIES – Benchmarking Quality
- Digital Transformation- Business & Clinical Capacity
- Transformation Projects: Analytics; Real-Time Health System Capabilities; Telehealth Services; Command Center Capabilities
- Command Center: Centralized Throughput Office (CTO)
- Command Throughput Office Dashboard
- Real-Time Dashboards
- Early Progress of Command Throughput Office (Boarders, Cases)
- Mobile STROKE Unit Program
- Telemedicine / TeleHealth
- Stony Brook University Hospital awarded $966,026
- Data Strategy in Decentralized Environment
- Call to Action for Startups
AI in Healthcare | Future of Smart Hospitals Renee Yao
In this talk, I specifically talk about how NVIDIA healthcare AI software and hardware were used to support healthcare AI startups' innovation. Three startups featured: Caption Health, Artisight, and Hyperfine. Audience: healthcare systems CXOs.
Personal connected health is currently characterized by limited thought leadership, insufficient coordination and collaboration, and a lack of awareness and understanding of the full potential by all stakeholders: public, providers, policymakers, industry and patients. The Personal Connected Health Alliance is defining the the field of personal connected health to inspire market and policy innovation, research and collective action for sustained adoption of personal connected health technology. The vision is better health and well being for all through increased personal responsibilities and connectivity as well as improved care delivery enabled by technology.
The potential of a digital health ecosystemVelametis
Our idea of digital health ecosystems and their potential to deliver value to all stakeholders involved, is changing. The COVID-19 pandemic accelerated the need to improve remote care, engagement tools and interconnectivity, which are all necessary to support a functioning digital ecosystem.
In this opinion piece, we touch upon the basic components of a Digital Health Ecosystem and how it can be optimised with health technology.
Content overview:
What is a Digital Health Ecosystem?
Why Do We Need Digital Health Ecosystems?
The Pros and Cons
The Potential
Digital Health Ecosystems to Watch
Download here:
https://velametis.com/the-potential-of-a-digital-health-ecosystem/
These slides use concepts from my (Jeff Funk) course entitled Biz Models for Hi-Tech Products to analyze the business model for Oscar Health Insurance. Unlike most health care insurance companies, Oscar focuses on end-users as opposed to companies. It connects end users with its network of health care providers (e.g., doctors, hospitals). It focuses on end-users, largely because America’s new health care plan, usually called Obamacare, opened up this opportunity for focusing on end-users, who didn’t have coverage through employers. Oscar reduces its costs through a simpler form of web-based billing, Telemedicine, and wearable technology. These slides describe the value proposition, customers, method of value capture, scope of activities and the method of strategic control for Oscar.
Creating large scale telehealth network : A story from the USA by Adam Darkins, Vice President, Medical Affairs & Enterprise Technology Development, Medtronics, USA
At eClinicalWorks, we are 5,000 employees dedicated to improving healthcare together with our customers. More than 130,000 physicians nationwide — and more than 850,000 medical professionals around the globe — rely upon us for comprehensive clinical documentation, along with solutions for Practice Management, Population Health, Patient Engagement, and Revenue Cycle Management.
Providers need to move towards real-time analytics that have become critical to demonstrate their quality of care, as reimbursement by government programs can be contingent upon how providers are measured in “Quality of Care”. For example, the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, also called the Permanent Doc Fix, changes the way Medicare doctors are reimbursed with the implementation of a merit based incentive. The performance-based pressure is huge, which makes it imperative that every provider consider technology solutions. Read more at https://www.solix.com/solutions/data-driven-solutions/healthcare/
HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Manu Varma, PhilipsHxRefactored
Through new telehealth technologies and increased data analysis physicians are gaining insights into patients like never before, allowing them to facilitate early interventions, improve adherence, and reduce readmission rates -- not to mention at a price more affordable than ever. The companies you’ll hear from in this session are using a healthy and innovative mix of data, educational tools, sensors, and more to improve patient outcomes.
Patient centricity and digital solutionsAhmed Graouch
Beyond product offerings, it also positions Medtech companies to help hospitals and health systems transition to the future of health through services.
The term “digital twin” refers to the digital version of a physical device or process. By bridging the physical and the virtual worlds, data is transmitted seamlessly allowing the virtual entity to exist simultaneously with the physical device or process. Digital twins are emerging as virtual test beds for
possible solutions before they implement physical devices. These computer-based models are fed individual and population data and mimic the electrical and physical properties of an object.
Medical device companies are using this technology to simulate how their devices are being used in the
clinical setting.
In our view of the future of health, radically interoperable data is likely to play a huge role in transforming health care. Data from medical technologies such as wearables, remote monitors, and
sensors will be standardized, stored, updated, and aggregated with other sources of information such as social media platforms, retailers, and electronic health records.
The combined data will create a complete personal profile that physicians and health systems can use to help ensure that
I deliver health services in an appropriate fashion.
mHealth Israel_Hospitals and Healthcare Data_Carol Gomes_Stony Brook Universi...Levi Shapiro
Presentation by Carol Gomes, CEO / COO, Stony Brook University Hospital: Hospitals + Healthcare Data. Key Sections:
- Overview of Stony Brook Medicine Health System
- IT capital planning process
- Transition from Fee-for-Service
- Clinically Integrated Network
- Population Health Analytics Platform
- REGISTRIES – Benchmarking Quality
- Digital Transformation- Business & Clinical Capacity
- Transformation Projects: Analytics; Real-Time Health System Capabilities; Telehealth Services; Command Center Capabilities
- Command Center: Centralized Throughput Office (CTO)
- Command Throughput Office Dashboard
- Real-Time Dashboards
- Early Progress of Command Throughput Office (Boarders, Cases)
- Mobile STROKE Unit Program
- Telemedicine / TeleHealth
- Stony Brook University Hospital awarded $966,026
- Data Strategy in Decentralized Environment
- Call to Action for Startups
AI in Healthcare | Future of Smart Hospitals Renee Yao
In this talk, I specifically talk about how NVIDIA healthcare AI software and hardware were used to support healthcare AI startups' innovation. Three startups featured: Caption Health, Artisight, and Hyperfine. Audience: healthcare systems CXOs.
Personal connected health is currently characterized by limited thought leadership, insufficient coordination and collaboration, and a lack of awareness and understanding of the full potential by all stakeholders: public, providers, policymakers, industry and patients. The Personal Connected Health Alliance is defining the the field of personal connected health to inspire market and policy innovation, research and collective action for sustained adoption of personal connected health technology. The vision is better health and well being for all through increased personal responsibilities and connectivity as well as improved care delivery enabled by technology.
The potential of a digital health ecosystemVelametis
Our idea of digital health ecosystems and their potential to deliver value to all stakeholders involved, is changing. The COVID-19 pandemic accelerated the need to improve remote care, engagement tools and interconnectivity, which are all necessary to support a functioning digital ecosystem.
In this opinion piece, we touch upon the basic components of a Digital Health Ecosystem and how it can be optimised with health technology.
Content overview:
What is a Digital Health Ecosystem?
Why Do We Need Digital Health Ecosystems?
The Pros and Cons
The Potential
Digital Health Ecosystems to Watch
Download here:
https://velametis.com/the-potential-of-a-digital-health-ecosystem/
These slides use concepts from my (Jeff Funk) course entitled Biz Models for Hi-Tech Products to analyze the business model for Oscar Health Insurance. Unlike most health care insurance companies, Oscar focuses on end-users as opposed to companies. It connects end users with its network of health care providers (e.g., doctors, hospitals). It focuses on end-users, largely because America’s new health care plan, usually called Obamacare, opened up this opportunity for focusing on end-users, who didn’t have coverage through employers. Oscar reduces its costs through a simpler form of web-based billing, Telemedicine, and wearable technology. These slides describe the value proposition, customers, method of value capture, scope of activities and the method of strategic control for Oscar.
Implementation of Online Safety Incident Reporting System in a Tertiary Care Teaching Hospital by Dr. Bijoy Johnson, Dept. of Hospital Administration, KMC Manipal, India
Virtual knowledge network NIMHANS Echo : Innovative tele- mentoring model for skilled capacity building in addiction & mental health by Prabhat Chand , NIMHANS, India
Patient-Centered Care Requires Patient-Centered Insight: What We Can Do To C...Health Catalyst
Health systems and providers are inundated with measurement systems and reporting. Why would we want to add to the measurement mayhem? The real question is, “Are we measuring what matters?”
Carolyn Simpkins MD, PhD, chief medical informatics officer, will discuss how putting the patient at the center of the measurement matrix can bring coherence and completeness to the picture of care delivery performance across the patient journey, and therefore the performance of the healthcare ecosystem.
She will describe the building blocks for patient-centered measurement and how other metrics, patient-reported outcomes, and patient satisfaction fit into this approach. Carolyn will also review the challenges that have kept health systems from completing a patient-centered outcomes approach and why we are poised to break through. Finally, she will share case studies of organizations who have begun to pioneer the use of patient centered metrics to improve care and outcomes.
Predictive Risk Stratification: Using Analytics to Empower Change with Action...Health Catalyst
Effective population health initiatives are challenging to implement for a variety of reasons. Care teams are already overburdened, and healthcare data is challenging to aggregate and analyze. These factors make it difficult to accurately identify patients who are high-risk or have rising risk for poor outcomes and provide appropriate intervention. To manage patient populations effectively and efficiently, healthcare organizations must be able to automate predictive risk stratification based on claims data, clinical data, and social determinants of health. When care teams know which patients need the most help, which patients have rising risk, and which patients are healthy, they can focus their valuable time where it’s needed most. In this webinar, Dr. Welch shares best practice strategies for utilizing analytics that empower change with actionable workflows, like patient engagement, to ensure that clinically integrated entities can manage high-risk populations appropriately, while also caring for those with rising risk, and engaging with healthy populations mapped to the right targeted interventions.
The Future of Personalized Health Care: Predictive Analytics by @Rock_HealthRock Health
View the archived webinar here: https://www.youtube.com/watch?v=UJak41hIDWc
How can we use new and existing sources of data to deliver better, personalized care? Predictive analytics underlies what has always been conducted by doctors through their training, experience, and decision-making. Dozens of new digital products have hit the market and $1.9B has flowed into the space since 2011—but what does it take for an algorithm to accurately and reliably impact care?
Purchase the report here: https://gumroad.com/l/gzbzV
Care Management - Critical Component Of Effective Population HealthHealth Catalyst
In this first webinar, of a two-part series, Dr. Kathleen Clary will share how analytics can be used to answer these questions to ensure delivery of a well-organized and effective care management program.
Dr. Clary will discuss how analytics can enable:
Data integration from multiple EMRs and data sources
Patient stratification and intake
Care coordination
Patient engagement
Performance measurement
We look forward to you joining us!
mHealth Israel_Future of Integrated Individualized Healthcare_Roche DiagnosticsLevi Shapiro
Presentation by Alexandra Eberhard, Sr. Director, Global Business Development, Roche Diagnostics on the "Future of Integrated Individualized Healthcare". Includes background about Roche Diagnostics and investments in innovation. Overview of Roche products and solutions with a portfolio covering the entire spectrum of diagnostics users. Emphasis on the triple aim of healthcare- The power of data and technology to enable the transformation from volume- to value-based healthcare. Interest in data for Pharma - drive more efficient R&D; DIA - develop novel patient care Dx solutions. Focus on the needs of labs, physicians & payers for better patient health. A suite of digital solutions that improve clinical & business outcomes. Suite of solutions to optimize the lab. Translating data into insights to achieve financial goals. A move from volume- to value-based care. New opportunities in the disease continuum- Holistic solutions approach. Expanding the focus towards earlier in the patient journey. Doing now what patients need next. Contact Alexandra Vallon-Eberhard, PhD MBA; Sr. Director Global Business Development; Diagnostics Lead for Innovation in Israel; Based in Basel, Switzerland; Email: alexandra.vallon_eberhard@roche.com
Real world data is no longer just for those trained in health economics and outcomes research — it can and will touch everyone in the pharma/healthcare space.
CBI asked industry's foremost RWD thought leaders a variety of questions to better understand how bio/pharmaceutical teams can collaborate and capture data in an aggregated form to continue to improve the value of products in development with real world, real-time data.
Real World Data - The New Currency in HealthcareJohn Reites
White paper published in June 2015 by CBI Life Sciences with interview insights from John Reites.
Real World Data (RWD) have become the bio/pharmaceutical industry’s treasure trove for information to inspire stakeholder decision-making. As an industry, professionals have increasingly been looking to RWD to not only assess the bene ts and risks of new medicines in clinical and real world settings, but also as a way to advise healthcare reimbursement decisions worldwide.
How Pharma Can Use Digital Health to Drive Value | A Medullan WebinarMedullan
With the shift to value, healthcare payers are insisting that pharmaceutical manufacturers deliver real world evidence of their drug’s efficacy before being allowed on formulary. The cost of new specialty treatments has forced companies to bolster and go beyond clinical trial, proving that their drugs improve health outcomes and reduce the cost of care with real world evidence.
So how do pharmaceutical companies gather these data points and what kind of digital tools should they use?
Before we change actions or activities within the healthcare, the first point is to understand how staff and consumers think about the system we are in now.
'Content and customer-centricity - how to get beyond the hype and create real...B2B Marketing
A large part of our organizations claims that we are customer-centric. Is it the truth or a buzz word?
This talk aims at sharing learning’s about a major shift in content development strategy from a focus on individual products to an integrated portfolio proposition. We needed to articulate a more strategic proposition according to customers’ value drivers in order to build a more effective differentiation vs. competition.
Seamless Journey from Population Health to Precision MedicineOrion Health
Precision medicine is happening now! Join us as we examine the opportunities to leverage your initial core data sets and prepare for new data types to deliver real-time population health and precise medicine.
This webinar will demonstrate how modern healthcare organizations (HCO) are expanding clinical integration and upgrading to higher performing technology stacks on their journey to the omics-based and real-time delivery of precision medicine.
We’ll chat with Dr. Chris Hobson, CMO and CPO at Orion Health, Doctor Dylan Mordaunt, Clinical Director Research at Orion Health, and with Orion Health’s Executive Vice President of Product and Strategy, Dave Bennett about the importance of real-time data mining and re-mining, and which new computational tools and techniques you need to meet your population health goals and future proof your organization for the delivery of precision medicine.
In this webinar, we will explain:
How new models of medicine (e.g., molecular medicine, value-based medicine, etc.) are driving the immediate need for patient-specific decision support assistance
How existing and new data sets can be leveraged with integrated and real-time analytics (e.g., family history, pharmacogenics) for immediate reduction in adverse events and improved outcomes
How innovative organizations are answering this demand with high-performing technology
In this report we set out ten provocative statements predicting the world of 2020. Each prediction is articulated and brought to life through a series of portraits which imagine how patients, healthcare professionals and life sciences organizations might behave in this new world. Our predictions lean more towards an optimistic view of the future, although we organized that many in our industry are organized about the constraints and therefore pace of change. We describe the big trends rolled forward to 2020 and some of the constraints that will need to be overcome.
We also provide examples and evidence, based on the here and now, that show that the predictions are perfectly plausible, perhaps inspiring and surprising!
Our industry is changing quickly – requiring a bold response that is often difficult to implement – and yet organizations struggle to understand how to respond effectively and build a sense of urgency. We hope this report creates rich dialogue and enables a move to action.– we have had enormous fun discussing these predictions and sharing our experiences. We hope you have the same experience within your own organizations as you peruse this report and reflect on your current situation and future scenarios.
Accenture Digital Health Technology Vision 2016: Digital Health Leveraging Predictive Analytics to transform care at scale with intelligent service platforms
https://mhealthinsight.com/2016/06/27/join-us-at-the-kings-funds-digital-health-care-congress/
https://mhealthinsight.com/2016/06/27/join-us-at-the-kings-funds-digital-health-care-congress/
In this webinar, you will learn:
How we approach intervention campaigns: a framework
The science of behavior change and how it can be applied to increase the probability of desired outcomes
How Altarum’s ACE Measure can help predict consumer behaviors and design successful intervention campaigns
Speakers:
Ryan Rossier, Medullan
Chris Duke, Altarum
Josh Klapow, ChipRewards
Large Scale Disaster Management in Healthcare Deploying ICT by Olav Veum Eielsen Anesthesiologist, Director Regional Centre for Medical Emergency Research and Development,
Norway
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
How many patients does case series should have In comparison to case reports.pdf
VItreosHealth
1. ALL MATERIAL PROPRIETARY AND CONFIDENTIAL.
ALL MATERIAL PROPRIETARY AND CONFIDENTIAL.
PRODUCT SOLUTION OVERVIEW
2. ALL MATERIAL PROPRIETARY AND CONFIDENTIAL.
WHO WE ARE
Advanced analytics for Population Health through the use of Predictive and Prescriptive Insights
the bridge between Hindsight and Foresight – for actionable answers that impact outcomes. Globo Vitreo.
Used by Providers – IDNs, ACOs, large medical practice groups, and health systems
to manage “at-risk” populations and position for success in value-based care model
to improve outcomes and maximize revenues
Used by Payers – Self Insured, Medicare & Medicaid HMOs
to reduce medical loss ratios (MLR)
2016 Winner of Frost & Sullivan’s New Product Innovation Award for Advanced Population Health Analytics
Solutions - North America
VitreosHealth Selected as 20 Most Promising Healthcare Analytics Solution Providers of 2016 by Healthcare
Tech Outlook
2 0 1 5 : 4 0 0 % G R O W TH A N D D O U B L E D C L I E N T B A S E , 2 0 1 6 : S E C U R E D $ 5 M O F P E F I N AN C I N G
7. ALL MATERIAL PROPRIETARY AND CONFIDENTIAL.
ALL MATERIAL PROPRIETARY AND CONFIDENTIAL.
STATE OF HEALTH ANALYSIS (SOHA)
QUICK ASSESSMENT OF THE OPPORTUNITIES FOR YOUR POPULATION
(3-4 WEEK STUDY)
8. ALL MATERIAL PROPRIETARY AND CONFIDENTIAL.
THE OLD WAY: ONE-DIMENSIONAL
STRATIFICATION
(HEALTHCURE, NOT HEALTHCARE)
8
Critical
High Utilizers
Moderate risk
Healthy
50%
25%
15%
10%
$52M
$26M
$15.6M
$10.4M
$104M
$850
10,507
2013 TOTAL 2014 TOTAL
$157.2M
$1,187
11,038
9. ALL MATERIAL PROPRIETARY AND CONFIDENTIAL.
Page 9
THE NEW PARADIGM: PRAGMATIC COST/RISK
STRATIFICATION
10. ALL MATERIAL PROPRIETARY AND CONFIDENTIAL.
IDENTIFYING ‘MOVER’ COHORTS
In one year ~14 % Population moved from left to right to create additional
~40% Cost.
12. ALL MATERIAL PROPRIETARY AND CONFIDENTIAL.ALL MATERIAL PROPRIETARY AND CONFIDENTIAL.
THANK YOU
12
Shanthan Ramasahayam
We appreciate your partnership
President (India Operations)
sramasahayam@vitreoshealth.com
VitreosHealth.com
Editor's Notes
Hello everyone, my name is Shanthan. Thank you so much for taking this time for this presentation. I’ll start right off with an overview of VitreosHealth and move onto the demo. Let me know if you have any questions along the way.
So here’s a sample of some of our customers and as you can see there are health plans, large systems, provider groups, ACOs and, hospitals. Even though different they are all on the hook for controlling costs and making savings at the end of the year. And we’ve helped them get there by improving outcomes and controlling costs. And later in my presentation I’ll show you a little bit of what we’ve done for them and what we can do for you. I’ll also touch on outcomes and how we get to those outcomes with these customers.
And then we are really proud that Dell and E&Y have chosen us as their predictive population health partner across their customer base.
STOP
I’m sure you recognize some of these names and you can see there are health plans, large systems, provider groups, ACO ands, hospitals. We have many different types of customers (but one thing that they all have in common is they have all taken risk. Meaning they) that are all on the hook for controlling costs and making savings at the end of the year. And we’ve helped them get there by improving outcomes and controlling costs.
Our customers range from healthcare systems like cone heath in north Carolina, to Christus Trinity Mother Francis in Texas. We have large medical groups like USMD, patient physician network and payers like global health and EasyChoice which is under WellCare health plans. And two of our key strategic partners are dell healthcare and earnst and young who have chosen us as their predictive population health partner across their customer base.
So something I like to start out with is what makes us different- and that is how we approach the data sets. So many companies that you come across today who say they do predictive ananytics are commonly focused on claims and sometimes one other data set. Our models are built to include both clinical and non-clinical factors. And those clinical factors include both physical and mental health and then non-clinical like socio-economic status or access to care.
So difference #1 we have the ability to take in all of these meaningful data sets and difference #2 we use your data to customize our models. Both of these make our accuracy rate much high than our competitors. We’ve seen that every customer and their data capabilities are different so we can start with whatever data you have and build from there. As we are able to add additional information our accuracy increases even more and this slide shows how much of an impact this can make.
STOP
The value in our service starts with ability to include meaningful data sets into our models. We use a strong mix of Clinical and Non-Clinical information to strengthen the predictive power of our Insights.
Slides – This is who we are, What we do and how we do it…. One or two slides about state of health analysis….
If you have Claims data only we can provide much greater statistically relevant data vs. the competition because of our approach. Using historical data, regression testing and looping in the socioeconomic data our accuracy rate is second to none. As we are able to add additional information our accuracy increases and this slide shows how much of an impact this can make. As shared risk programs become more of the norm our clients are partnered with someone that has already built this infrastructure. You don’t have to use a vendor with limited capabilities when you have limited data sets. Plan for the future by using a solution built for the future.
Instead of using the Pyramid we use a multi-dimensional model and plot the population on this 2x2 grid. We say the state of health of a member is not just based on historical cost but also based on clinical risk. Now looking at..
critical, we know who these patients are, they are the patients with a high risk and high cost.
Bellow that is the high utilizers, those are the ones that historically have been high cost but have a low clinical risk. Many of these patients end up in the emergency room, or have a substance abuse problem. And the root cause of these costs may not even be clinical, it could be socioeconomic. But what are less known are the other two categories.
So the hidden category- are the patients that are at a high clinical risk but they aren’t on your radar because they’ve had low cost. But it’s just a matter of time until these patients are gong to have a high cost event, move to the critical category and cost you a ton of money.
And then the healthy/unknown category these patients may have huge gaps in care, they may have a high socio-economic risk, but you don’t know because you don’t have any information on them, and if you don’t have care managers actively reaching out to them and getting that information they may soon move to the critical or high utilizers category. So you need to know who they are before they make this move.
STOP
The problem with traditional charts is they are one-dimensional. So the starting point for our analysis is multi-dimensional where we put cost and risk together and stratify the population.
If advanced audience can add this:
{On the y-axis is a predicted risk score, that represents the probability that the patient is going to have a high cost intervention due to a complication with one or more current diseases. The x-axis is a historical looking measure of utilization.}
And what this does is categorizes patients into the four buckets you see here.
The top right are high cost high risk, we call those the critical patients.
Bellow that is the high utilizers, those are the ones that historically have been high cost but have a low clinical risk. Many of these patients end up in the emergency room, or have a substance abuse problem. And the root cause of these costs may not even be clinical. It could be socioeconomic, maybe they can’t afford co-pays or afford a taxi to appointments. These are gonna be the patients you may have already identified because of their high spend and the ones that may already be in your care management programs.
But what are less know are the other two categories, so the hidden category is the patients that are clinically at a high risk but historically have been low cost. What this means is these patients are high risk because one or more of their diseases is out of control. Maybe their A1C is high, maybe their BMI is high, they have multiple comorbidities, their cholesterol levels are high, they haven’t seen a doctor in over two years. All of this could contribute to why they are at a high risk, but you’ve just been lucky that they have not had a high cost event. So we call them the hidden opportunity, the ticking time bombs, rising risk population. This group is very important because if you don’t take care of them it’s only a matter of time before they hit the emergency room and then it will be too late because that CAD patient just had a stroke or that diabetic patient just had renal failure. And they are now going to move to the right and become critical. You have to then manage renal failure for the rest of the patient’s life and they will continue to be high cost.
Similarly, the healthy and unknown category is interesting because a lot of patients there are healthy, they don’t have many chronic conditions and many of them are young. But some of them might end up moving to the right because of a non-clinical factor, like socioeconomic status or due to mental health issues and s become high cost, so you need to know who they are before they make this move. And this category also includes unknown, so patients that have just joined your plan or network and you have no history. No clinical history, no claims history so they are unknown. At most you may do a risk assessment on them and you may get a little bit of information.
But we find that many of these patients are in fact not healthy and very quickly they end up moving, and that’s why it’s so important to know who those unknowns are and get whatever information you can on them so that they can be stratified and categorized appropriately.
So we took that Medicare ACO population and used our 2x2 grid to stratify the patients for years 1 and 2. We then did a mover analysis to see where the patients were moving during those years... And what we found was 508 members moved from the healthy category to the high utilizers category and accounted for $18.7M in new spend and 754 members moved from the hidden category to the critical category and accounted for $28.5M in new spend. SO the original theory that the $53.2M in new spend was attributed to new members joining and costly members becomomg more costly was wrong. The majority of the spend was actually from current members moving to the left becoming more costly.
So the question becomes what if this ACO focused all of their time and resources on the people on the left so that they didn’t move to the right? This is millions of dollars they could have saved by addressing the right patients that were already in their population. But they were spending all of their time on the critical population.
We aren’t here to rip and replace investments you have already made. We want to help maximize what you are already doing with our closed loop analytics piece and then if you don’t have a care management application then we can provide that as well. We will tell you who the risky patients are, Why they are risky, What you can do about it and then tell you how your population and programs are doing. So we are really here to help you be successful and be that partner in your move to value based care.
Any questions on that?
So now I’m going to show you a brief overview of demo but keep in mind we are going to be doing this for you as a service. We don’t sell an application we sell insights into your population.
STOP
Because we are managing this population there are many different thing we can look at. We aren’t trying to displace any other solutions or programs that you currently have, but if we can add value we will definitely do that.
So at the end of the day we are a closed loop analytics process and we can help you wherever you may be in the move to value based care.
We aren’t here to rip and replace investments you have already made. We want to help maximize what you are already doing with our closed loop analytics piece and if you don’t have a care management application then we can provide that as well. We will tell you who the risky patients are, Why they are risky, What you can do about it and then on a monthly basis tell you how your population is doing.
We can also work with your current solutions to deliver complete insights as a service. We can add to your work flow applications
Our closed loop process has either 3-5 steps depending on what you are currently doing. We can do the entire 5 step loop including the analytics, soha, care management platform and performance results or we can just be your pure ananlytics engine and imbed ourselves in current workflow applications.
As I go through the demo there are 5 steps I’m going to cover, and these are the 5 steps in what we call the Closed Loop Process for Population Health Management.
o Step 1 is to analyze my population. So let’s stratify and segment these patients into groups.
o Step 2 show me the risky patients. This is who we predict is going to move from a low to a high risk.
o Step 3 show me why they are risky. Show me the risk factors, show me the gaps in care- show me anything I need to know about these patients.
o Step 4 now with all of this information tell me what I need to do, do I need to bring these patients in, do I need to close gaps. And who's going to do it? Do I need to do everything or get the help of a social worker? In other words, help me put a program together.
o Step 5 measure the outcomes and tell me if what we’re doing is working or not working. And don't wait till the end of the year, tell me every month, every quarter, so if something isn’t working I can fix it.
And doing this we have a closed-loop process that will continually help us improve and ultimately bend the cost curve.